RaySearch signs agreement with B dot Medical for development of advanced software solutions for proton therapy
13 Jun 2023
STOCKHOLM, June 13, 2023 /PRNewswire/ --RaySearch Laboratories AB (publ) is pleased to announce a strategic collaboration agreement with B dot Medical Inc. aimed at advancing the field of proton therapy by development and validation of intregrations between RaySearch's treatment planning system RayStation®*, oncology information system RayCare®* and B dot Medical's ultra-compact proton therapy system.
B dot Medical is a Japanese company dedicated to the development of an ultra-compact proton therapy system with a non-rotating gantry, which is focused on achieveing exceptional irradiation performance, including cutting-edge features such as high-speed scanning and respiratory-gated irradiation.
The collaboration aims at expanding the accessibility and availability of proton therapy technology to a wide range of healthcare facilities and regions worldwide. Ultimately, the goal is to benefit patients by making proton therapy more accessible.
Takuji Furukawa, President and CEO, B dot Medical, says: "This collaboration represents a significant step forward in our mission, "proton for everyone". By partnering with RaySearch, we can further optimize the capabilities of our systems, bringing innovative solutions to the field of radiation oncology. We are excited about the impact this collaboration will have on patient care and will accelerate our business to expand the market for radiotherapy and propose optimal solutions to hospitals."
Johan Löf, founder and CEO, RaySearch, says: "We are thrilled to join forces with B dot Medical in this groundbreaking collaboration. By combining our respective expertise, we can drive innovation and contribute to the advancement of proton therapy technology. Together, we are committed to improving cancer treatment outcomes and making proton therapy more accessible to patients globally."
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com
The following files are available for download:
View original content:
SOURCE RaySearch Laboratories
Company Codes: Bloomberg:RAYB@SS, ISIN:SE0000135485, RICS:RAYB.ST, Stockholm:RAYB
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.